Exploring how riluzole, an ALS drug, shows promise in treating Alzheimer's disease by targeting glutamate regulation and neuroprotection.
Exploring riluzole, an FDA-approved ALS drug, as a potential treatment for Alzheimer's disease by targeting glutamate dysregulation.